Replies to post #9812 on BioCorRx Inc. (BICX)

[Admtiger]

that would be nice but didn't Brady say it was suggested they work on their implant.

[Thirdeyeblind]

Why cancel the IND meeting? Because if they had the meeting the company would know what the FDA expected, the projected costs, the risks etc of pursuing bicx101 and they know they could never afford the process, they can't even afford the fee for the new drug application. With no real info, little investors drrams go wild, with specific FDA info even a little investor can figure out that bicx can't possibly afford the FDA requirements.